Medaco (Holdings) Limited 09055710 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.30.9574.0 true false false 09055710 2024-01-01 2024-12-31 09055710 2024-12-31 09055710 core:ShareCapital 2024-12-31 09055710 core:SharePremium 2024-12-31 09055710 core:Non-currentFinancialInstruments 2024-12-31 09055710 bus:SmallEntities 2024-01-01 2024-12-31 09055710 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 09055710 bus:FullAccounts 2024-01-01 2024-12-31 09055710 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09055710 bus:RegisteredOffice 2024-01-01 2024-12-31 09055710 bus:Director1 2024-01-01 2024-12-31 09055710 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09055710 core:Subsidiary1 2024-01-01 2024-12-31 09055710 core:Subsidiary1 1 2024-01-01 2024-12-31 09055710 core:Subsidiary1 countries:England 2024-01-01 2024-12-31 09055710 countries:AllCountries 2024-01-01 2024-12-31 09055710 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 09055710 2023-01-01 2023-12-31 09055710 2023-12-31 09055710 core:ShareCapital 2023-12-31 09055710 core:SharePremium 2023-12-31 09055710 core:Non-currentFinancialInstruments 2023-12-31 09055710 core:Subsidiary1 1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 09055710

Medaco (Holdings) Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 December 2024

 

Medaco (Holdings) Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Medaco (Holdings) Limited

(Registration number: 09055710)
Abridged Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Investments

4

100

100

Current assets

 

Debtors

5,878

5,878

Cash at bank and in hand

 

900

900

 

6,778

6,778

Net assets

 

6,878

6,878

Capital and reserves

 

Called up share capital

2,002

1,001

Share premium reserve

4,876

5,877

Total equity

 

6,878

6,878

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the Company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 9 May 2025 and signed on its behalf by:
 

J P Smallridge

Director

 

Medaco (Holdings) Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales (Registered number: 09055710).

The address of its registered office is:
Unit 109 Longmead Road
Emerald Park East
Emersons Green
Bristol
BS16 7FG

These financial statements were authorised for issue by the Board on 9 May 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable the future economic benefits will flow into the entity, and specific criteria have been met for each of the company activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in the profit or loss account. Investments in equity shares where fair value cannot be measured reliably are measured at cost less impairment.

 

Medaco (Holdings) Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 December 2024

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 4).

4

Investments

Total
£

Cost or valuation

At 1 January 2024

100

Provision

Carrying amount

At 31 December 2024

100

At 31 December 2023

100

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2024

2023

Subsidiary undertakings

Medaco Limited

Unit 109 Longmead Road
Emerald Park East
Emersons Green
Bristol
BS16 7FG

England

Ordinary Shares

100%

100%

Subsidiary undertakings

Medaco Limited

The principal activity of Medaco Limited is providing goods and services to the healthcare industry.